Eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After Dosing

OBJECTIVE: To determine the onset of preventive efficacy with eptinezumab in patients with migraine. BACKGROUND: Eptinezumab is a monoclonal antibody inhibiting calcitonin gene‐related peptide approved as an intravenously administered treatment for the prevention of migraine. METHODS: Patients who r...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Headache
Main Authors: Dodick, David W., Gottschalk, Christopher, Cady, Roger, Hirman, Joe, Smith, Jeff, Snapinn, Steve
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2020
Fag:
Research Submissions
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7756794/
https://ncbi.nlm.nih.gov/pubmed/33165938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/head.14007
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker